A.M.S. SPRL
A.M.S. reported total assets of 53,481 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).
The score of A.M.S. shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -75 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
A.M.S.'s annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 28,388 € | ||||
| Equity | −16,560 € | ||||
| Cash | 39,219 € | ||||
| EBITDA | 38,749 € | ||||
| Total assets | 53,481 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 06 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 24 Aug 2022
A.M.S.'s financial analysis
- Solvency-31.0%sector median: 46.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of A.M.S.
A.M.S.'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0460.750.196
- VAT number
- BE0460750196
- Peppol
- Registered · 0208:0460750196 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 29 May 1997
- Registered office
- 6536 Thuin
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses (NACE 47741)
A.M.S. (SPRL) has been based in Thuin since 1997, active in: retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses. For 2025, it reports a net profit of 28,388 € and equity of −16,560 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to A.M.S.
Companies in the same business, of comparable size and area, outside its group.
- C.G.D. Ducarmois Retail sale of medical and orthopaedic goods Gerpinnes · balance sheet 13,961 €
- Cabinet Infirmier Falisse-Audin Retail sale of medical and orthopaedic goods Charleroi · balance sheet 257,182 €
- SH Audio Retail sale of medical and orthopaedic goods Molenbeek-Saint-Jean · balance sheet 62,329 €
- Ebgpur Retail sale of medical and orthopaedic goods Sint-Truiden · balance sheet 63,081 €
- Chemliro Retail sale of medical and orthopaedic goods Roeselare · balance sheet 67,557 €
- Dewinju Retail sale of medical and orthopaedic goods Destelbergen · balance sheet 42,267 €
- aks Retail sale of medical and orthopaedic goods Nieuwerkerken (Limb.) · balance sheet 68,773 €
- Lavisaine Retail sale of medical and orthopaedic goods Brussels · balance sheet 66,977 €
Frequently asked questions about A.M.S.
What is the revenue of A.M.S.?
A.M.S. files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of A.M.S.?
In Belgium, the VAT number is the company number prefixed with BE: BE0460750196 for A.M.S., if the company is VAT-registered. Its company number (CBE) is 0460.750.196.
Where is the registered office of A.M.S.?
According to the CBE register, the registered office of A.M.S. is in 6536 Thuin.
What is the equity of A.M.S.?
At the close of the 2025 financial year, the equity of A.M.S. amounts to -16,560 €, a solvency of -31.0% of total assets.
Who manages A.M.S.?
The register lists 1 active mandates at A.M.S.. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of A.M.S.
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →